TransCode Therapeutics, Inc. Common Stock

Go to TransCode Therapeutics, Inc. Common Stock Website

$0.44

(%)
Live
Previous Close

$0.4399

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$2.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanopar...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

TransCode Therapeutics Reports 2023 Results; Provides Business Update

Related tickers: RNAZ.

Read Full Article

TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer

Related tickers: RNAZ.

Read Full Article
Trending Tickers
DATS

XNAS

$1.28
(%)
LASE

XNAS

$2.07
(%)
NYCB

XNYS

$3.06
(%)
PACW

XNAS

$7.54
(%)
MLGO

XNAS

$2.59
(%)